A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms.
Frontiers in Molecular Biosciences; doi: 10.3389/fmolb.2020.00048.
Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer’s Disease.
J Alzheimers Dis.; doi: 10.3233/JAD-190604.
Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation.
J Biol Chem.; doi: 10.1074/jbc.RA119.009487.
Highly sensitive quantification of Alzheimer's disease biomarkers by aptamer-assisted amplification.
Theranostics; DOI: 10.7150/thno.29232.
Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide Standard.
Journal of Proteome Research; https://doi.org/10.1021/acs.jproteome.8b00920.
ATAD3A oligomerization causes neurodegeneration by coupling mitochondrial fragmentation and bioenergetics defects.
Nature Communications; https://doi.org/10.1038/s41467-019-09291-x.
Dural lymphatics regulate clearance of extracellular tau from the CNS.
BioMed Central; https://doi.org/10.1186/s13024-019-0312-x.
Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors.
Science Advances; DOI: 10.1126/sciadv.aau3333.
Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression.
Scientific Reports; DOI:10.1038/s41598-018-35130-y.
In vitro generation of tau aggregates conformationally distinct from parent tau seeds of Alzheimer’s brain.
Prion; https://doi.org/10.1080/19336896.2018.1545524.